Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging

Methotrexate (MTX) is an immunosuppressant commonly used for the treatment of autoimmune diseases. Recent observations have shown that patients treated with MTX also exhibit a reduced risk for the development of cardiovascular disease (CVD). Although MTX reduces systemic inflammation and tissue dama...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmerman, Matthew C., Clemens, Dahn L., Duryee, Michael J., Sarmiento, Cleofes, Chiou, Andrew, Hunter, Carlos D., Tian, Jun, Klassen, Lynell W., O’Dell, James R., Thiele, Geoffrey M., Mikuls, Ted R., Anderson, Daniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552384/
https://www.ncbi.nlm.nih.gov/pubmed/28803127
http://dx.doi.org/10.1016/j.redox.2017.07.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552384/
https://www.ncbi.nlm.nih.gov/pubmed/28803127
http://dx.doi.org/10.1016/j.redox.2017.07.018

Ejemplares similares